美国FDA生物制品紫皮书数据库
(U.S. FDA Purple Book: Database of Licensed Biological Products)
商品名 申请号 产品号 BLA类型 非专利名称 剂型 给药途径 规格/剂量 产品形式 批准日期 申请人 市场状态 许可证状态 参考产品非专利名称 参考产品专利名称
Octagam 125062 007 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 10% 5G Single-Use Bottle 2014/07/11 Octapharma Pharmazeutika Produktionsges.m.b.H. Rx Licensed N/A
Octagam 125062 008 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 10% 2G Single-Use Bottle 2014/07/11 Octapharma Pharmazeutika Produktionsges.m.b.H. Rx Licensed N/A
Octagam 125062 009 351(a) Immune Globulin Intravenous (Human) Injection Intravenous 10% 10G Single-Use Bottle 2014/07/11 Octapharma Pharmazeutika Produktionsges.m.b.H. Rx Licensed N/A
Afrezza 022472 001 351(a) insulin human Powder Inhalation 4UNITS/INH Single-Dose Cartridge 2014/06/27 Mannkind Corporation Rx Licensed N/A N/A
Afrezza 022472 002 351(a) insulin human Powder Inhalation 8UNITS/INH Single-Dose Cartridge 2014/06/27 Mannkind Corporation Rx Licensed N/A N/A
Alphanate 102475 005 351(a) Antihemophilic Factor/von Willebrand Factor Complex (Human) For Injection Intravenous 2000IU Single-Dose Vial 2014/06/26 Grifols Biologicals LLC Rx Licensed N/A
Eloctate 125487 001 351(a) Antihemophilic Factor (Recombinant), Fc Fusion protein For Injection Intravenous 1500IU Single-Dose Vial 2014/06/06 Bioverativ Therapeutics, Inc. Rx Licensed N/A
Eloctate 125487 002 351(a) Antihemophilic Factor (Recombinant), Fc Fusion protein For Injection Intravenous 1000IU Single-Dose Vial 2014/06/06 Bioverativ Therapeutics, Inc. Rx Licensed N/A
Eloctate 125487 003 351(a) Antihemophilic Factor (Recombinant), Fc Fusion protein For Injection Intravenous 2000IU Single-Dose Vial 2014/06/06 Bioverativ Therapeutics, Inc. Rx Licensed N/A
Eloctate 125487 004 351(a) Antihemophilic Factor (Recombinant), Fc Fusion protein For Injection Intravenous 3000IU Single-Dose Vial 2014/06/06 Bioverativ Therapeutics, Inc. Rx Licensed N/A
Eloctate 125487 005 351(a) Antihemophilic Factor (Recombinant), Fc Fusion protein For Injection Intravenous 750IU Single-Dose Vial 2014/06/06 Bioverativ Therapeutics, Inc. Rx Licensed N/A
Eloctate 125487 006 351(a) Antihemophilic Factor (Recombinant), Fc Fusion protein For Injection Intravenous 500IU Single-Dose Vial 2014/06/06 Bioverativ Therapeutics, Inc. Rx Licensed N/A
Eloctate 125487 007 351(a) Antihemophilic Factor (Recombinant), Fc Fusion protein For Injection Intravenous 250IU Single-Dose Vial 2014/06/06 Bioverativ Therapeutics, Inc. Rx Licensed N/A
Evarrest 125392 003 351(a) Fibrin Sealant Patch Patch Topical 55.5MG FIBRINOGEN&241.9IU THROMBIN/IN^2; 2x4 IN Pouch 2014/05/27 Ethicon, Inc. Rx Licensed N/A
Entyvio 125476 001 351(a) vedolizumab For Injection Intravenous 300MG Single-Dose Vial 2014/05/20 Takeda Pharmaceuticals U.S.A., Inc. Rx Licensed N/A N/A
Sylvant 125496 001 351(a) siltuximab For Injection Intravenous 100MG Single-Dose Vial 2014/04/23 Recordati Rare Diseases, Inc. Rx Licensed N/A N/A
Sylvant 125496 002 351(a) siltuximab For Injection Intravenous 400MG Single-Dose Vial 2014/04/23 Recordati Rare Diseases, Inc. Rx Licensed N/A N/A
Cyramza 125477 001 351(a) ramucirumab Injection Intravenous 100MG/10ML (10MG/ML) Single-Dose Vial 2014/04/21 Eli Lilly and Company Rx Licensed N/A N/A
Cyramza 125477 002 351(a) ramucirumab Injection Intravenous 500MG/50ML (10MG/ML) Single-Dose Vial 2014/04/21 Eli Lilly and Company Rx Licensed N/A N/A
Ragwitek 125478 001 351(a) Short Ragweed Pollen Allergen Extract Tablet Sublingual 12 AMB A 1-UNITS/Tablet Blister Pack 2014/04/17 ALK - Abello A/S Rx Licensed N/A
当前数据更新日期:2025年12月20日,更多信息请点击此处查询美国FDA药品数据库

数据库说明:

©2006-2025 DrugFuture->U.S. FDA Purple Book